Search results
What to make of the new COVID variants, FLiRT
MPR News· 7 days agoThe good news: as of last Friday, the CDC says that the amount of respiratory illness in the U...The not-so-great news: The U.S. has often flirted with...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WSB-TV 2 Atlanta· 4 days agoWASHINGTON — (AP) — Government advisers Wednesday said it’s time to update the recipe for the COVID-...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
KRCG· 4 days agoGovernment advisers Wednesday said it's time to update the recipe for the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Stamford Advocate· 4 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
U-T San Diego· 4 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of ...
FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
The Nashua Telegraph· 4 days agoJackson-Hinds Comprehensive Health Center nurse Maggie Bass, right, gives a COVID-19 vaccine to an...
FDA Advisers Urge Targeting JN.1 Strain in Recipe for Fall's COVID Vaccines
US News & World Report· 4 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of ...
FDA advisers: Target JN.1 strain in fall’s COVID vaccine
The Columbian· 4 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
AOL· 4 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of ...
Opinion | Paxlovid Trial Flops for COVID Pneumonia
MedPage Today· 4 days agoIn 2021, nirmatrelvir/ritonavir clearly decreased hospitalization and death among COVID-19 patients who had high risks of severe disease and who had not...